Your browser doesn't support javascript.
loading
Retrospective analysis of safety and efficacy of anti-PD-1 therapy and radiation therapy in advanced melanoma: A bi-institutional study.
Mowery, Yvonne M; Patel, Kirtesh; Chowdhary, Mudit; Rushing, Christel N; Roy Choudhury, Kingshuk; Lowe, Jared R; Olson, Adam C; Wisdom, Amy J; Salama, Joseph K; Hanks, Brent A; Khan, Mohammad K; Salama, April K S.
Afiliação
  • Mowery YM; Department of Radiation Oncology, Duke University Medical Center, Durham, United States. Electronic address: yvonne.mowery@duke.edu.
  • Patel K; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, United States. Electronic address: kirtesh.patel@yale.edu.
  • Chowdhary M; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, United States. Electronic address: Mudit_Chowdhary@rush.edu.
  • Rushing CN; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, United States. Electronic address: christel.rushing@duke.edu.
  • Roy Choudhury K; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, United States; Department of Radiology, Duke University Medical Center, Durham, United States. Electronic address: kingshuk.roy.choudhury@duke.edu.
  • Lowe JR; Department of Medicine, Duke University Medical Center, Durham, United States. Electronic address: jared.lowe@duke.edu.
  • Olson AC; Department of Radiation Oncology, Duke University Medical Center, Durham, United States. Electronic address: olsonac2@upmc.edu.
  • Wisdom AJ; Duke University School of Medicine, Durham, United States. Electronic address: amy.wisdom@duke.edu.
  • Salama JK; Department of Radiation Oncology, Duke University Medical Center, Durham, United States. Electronic address: joseph.salama@duke.edu.
  • Hanks BA; Department of Medicine, Duke University Medical Center, Durham, United States. Electronic address: brent.hanks@duke.edu.
  • Khan MK; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, United States. Electronic address: m.k.khan@emory.edu.
  • Salama AKS; Department of Medicine, Duke University Medical Center, Durham, United States. Electronic address: april.salama@duke.edu.
Radiother Oncol ; 138: 114-120, 2019 09.
Article em En | MEDLINE | ID: mdl-31252292

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Radiother Oncol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Irlanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Radiother Oncol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Irlanda